Keisuke Hino

15.5k total citations · 1 hit paper
126 papers, 4.4k citations indexed

About

Keisuke Hino is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Keisuke Hino has authored 126 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Hepatology, 76 papers in Epidemiology and 15 papers in Rheumatology. Recurrent topics in Keisuke Hino's work include Liver Disease Diagnosis and Treatment (56 papers), Hepatitis C virus research (56 papers) and Hepatitis B Virus Studies (37 papers). Keisuke Hino is often cited by papers focused on Liver Disease Diagnosis and Treatment (56 papers), Hepatitis C virus research (56 papers) and Hepatitis B Virus Studies (37 papers). Keisuke Hino collaborates with scholars based in Japan, United States and United Kingdom. Keisuke Hino's co-authors include Sohji Nishina, Kiwamu Okita, Yuichi Hara, Akira Hiramatsu, Kyoji Moriya, Makoto Shiraki, Shuhei Nishiguchi, Hiroki Nishikawa, Masaaki Korenaga and Michiari Okuda and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Keisuke Hino

121 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria

2016 474 citations Keisuke Hino, Shuhei Nishiguchi et al. Hepatology Research profile →

Peers

Countries citing papers authored by Keisuke Hino

Since Specialization

Citations

This map shows the geographic impact of Keisuke Hino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keisuke Hino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keisuke Hino more than expected).

Fields of papers citing papers by Keisuke Hino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keisuke Hino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keisuke Hino. The network helps show where Keisuke Hino may publish in the future.

Co-authorship network of co-authors of Keisuke Hino

This figure shows the co-authorship network connecting the top 25 collaborators of Keisuke Hino. A scholar is included among the top collaborators of Keisuke Hino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keisuke Hino. Keisuke Hino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ferroptosis: biology and role in liver disease 2025 ·Journal of Gastroenterology ·Keisuke Hino, Sohji Nishina, Izumi Yanatori	0
2	HBV with precore and basal core promoter mutations exhibits a high replication phenotype and causes ER stress-mediated cell death in humanized liver chimeric mice 2023 ·Hepatology ·Takuro Uchida, Michio Imamura, C. Nelson Hayes, (unknown), (unknown), Kazuki Ohya, Hiroshi Aikata, Hiromi Abe‐Chayama, Yuji Ishida, Chise Tateno, Yuichi Hara, Keisuke Hino, Toru Okamoto, Yoshiharu Matsuura, Hideki Aizaki, Kenjiro Wake, Michinori Kohara, T. Jake Liang, Shiro Oka, Kazuaki Chayama	7
3	Objective Response by mRECIST Is an Independent Prognostic Factor for Overall Survival in Hepatocellular Carcinoma Treated with Sorafenib in the SILIUS Trial 2019 ·Liver Cancer ·Masatoshi Kudo, Kazuomi Ueshima, Yasutaka Chiba, Sadahisa Ogasawara, Shuntaro Obi, Namiki Izumi, Hiroshi Aikata, Hiroaki Nagano, Etsuro Hatano, Yutaka Sasaki, Keisuke Hino, Takashi Kumada, Kazuhide Yamamoto, Yasuharu Imai, (unknown), Chikara Ogawa, Takuji Okusaka, Fumihiko Kanai, Yasuaki Arai	12
4	Key HLA‐DRB1‐DQB1 haplotypes and role of the BTNL2 gene for response to a hepatitis B vaccine 2018 ·Hepatology ·Nao Nishida, Masaya Sugiyama, Hiromi Sawai, Sohji Nishina, Aiko Sakai, Jun Ohashi, Seik‐Soon Khor, Keisuke Kakisaka, (unknown), Keisuke Hino, Ryo Sumazaki, Yasuhiro Takikawa, Kazumoto Murata, Tatsuo Kanda, Osamu Yokosuka, Katsushi Tokunaga, Masashi Mizokami	45
5	Quantitative assessment of liver fibrosis reveals a nonlinear association with fibrosis stage in nonalcoholic fatty liver disease 2017 ·Hepatology Communications ·Yohei Masugi, Tokiya Abe, Hanako Tsujikawa, Kathryn Effendi, Akinori Hashiguchi, Masanori Abe, Yasuharu Imai, Keisuke Hino, Shuhei Hige, Miwa Kawanaka, Gotaro Yamada, Masayoshi Kage, Masaaki Korenaga, Yoichi Hiasa, Masashi Mizokami, Michiie Sakamoto	46
6	A follow-up survey of hepatitis virus carriers after notification of their infection in Okayama prefecture 2013 ·Kanzo ·Sohji Nishina, (unknown), (unknown), Tatsuya Itoshima, Kazuhide Yamamoto, Junko Tanaka, Keisuke Hino	1
7	Clinical usefulness of non‐protein respiratory quotient measurement in non‐alcoholic fatty liver disease 2013 ·Hepatology Research ·Keiko Korenaga, Masaaki Korenaga, (unknown), Toshiko Suzuki, Sohji Nishina, Kyo Sasaki, Yoshihiro Nakashima, Yasuyuki Tomiyama, Naoko Yoshioka, Yuichi Hara, Takuya Moriya, Keisuke Hino	5
8	3. Iron Metabolism Disorders and Iron Reduction Therapy in Patients with Chronic Liver Diseases. 2010 ·Nihon Naika Gakkai Zasshi ·Keisuke Hino, (unknown), Masaaki Korenaga	1
9	Clinical predictor for development of hepatocellular carcinoma in patients with primary biliary cirrhosis 2008 ·Kanzo ·Yasuyuki Tomiyama, Kenji Ohmoto, Naoko Yoshioka, Tomoya Kawase, Norikuni Shibata, Koji Yoshida, Makoto Kuboki, Keisuke Hino	4
10	Persistent Infection of Hepatitis C Virus and Hepatocarcinogenesis 2005 ·Keisuke Hino	0
11	Distinct geographic distributions of hepatitis B virus genotypes in patients with acute infection in Japan 2005 ·Journal of Medical Virology ·Hiroshi Yotsuyanagi, Chiaki Okuse, Kiyomi Yasuda, Etsuro Orito, Shuhei Nishiguchi, (unknown), Eiichi Tomita, Keisuke Hino, Kiwamu Okita, (unknown), Michio Sata, Hiromi Hoshino, Yuzo Miyakawa, Shiro Iino	49
12	Molecular epidemiologic analysis of hepatitis C virus infection in injecting drug users with acute hepatitis C in Japan 2004 ·Journal of Gastroenterology and Hepatology ·Yasuhiro Satoh, Keisuke Hino, Takanobu Kato, Masashi Mizokami, Satoyoshi Yamashita, Hiroki Nakamura, Kiwamu Okita	13
13	CASE REPORT: Reappearance of Hepatitis B Surface Antigen in Immunocompromised Individuals: Reinfection or Reactivation? 2002 ·Digestive Diseases and Sciences ·Keisuke Hino, (unknown), (unknown), (unknown), M. Jeffrey Mphahlele, Erasmus Smit, Siew Lin Ngui, Chong Gee Teo, William F. Carman	12
14	Apoptosis of human leukemia cells induced by Artepillin C, an active ingredient of Brazilian propolis. 2001 ·PubMed ·Tetsuo Kimoto, Mitsuharu Aga, Keisuke Hino, Satomi Koya‐Miyata, Yoshio Yamamoto, Mark Micallef, (unknown), Sadao Arai, Masao Ikeda, Masashi Kurimoto	107
15	Clinical implications of mutations C-to-T1653 and T-to-C/A/G1753 of hepatitis B virus genotype C genome in chronic liver disease 1999 ·Archives of Virology ·Kazuaki Takahashi, Yoshihiro Ohta, Koichi Kanai, Y. Akahane, Yasushi Iwasa, Keisuke Hino, Naofumi Ohno, Hiroshi Yoshizawa, Shunji Mishiro	66
16	Failed adoptive immunity transfer: reactivation or reinfection? 1999 ·Journal of Viral Hepatitis ·(unknown), Keisuke Hino, George Lau, (unknown), (unknown)	3
17	“Rebound” phenomenon of hepatitis C viremia after interferon therapy in “relapsed” patients with chronic hepatitis C 1995 ·Journal of Gastroenterology ·(unknown), Keisuke Hino, Kaori Fujii, M. Okazaki, Kiwamu Okita	2
18	Two cases of motor neuropathy during interferon-alpha 2a therapy for chronic active hepatitis type C. 1993 ·Kanzo ·(unknown), Keisuke Hino, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
19	3 cases of HBsAg carrier with fulminant liver failure induced by withdrawal of steroid therapy. 1988 ·Kanzo ·Hiroko Tanaka, (unknown), (unknown), Satoyoshi Yamashita, Fujio Murakami, (unknown), Keisuke Hino, (unknown), (unknown), (unknown), Kiwamu Okita, Tadayoshi Takemoto	1
20	Immunohistochemical study of glutathione S-transferase (GST-.PI.) on hepatocellular carcinoma. 1986 ·Kanzo ·Keiki Ogino, Isao Sakaida, (unknown), (unknown), Keisuke Hino, (unknown), (unknown), (unknown), Yuji Kado, (unknown), (unknown), (unknown), Kiwamu Okita, Tadayoshi Takemoto	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact